Von willebrand disease: Screening, diagnosis, and management

Aesthetic Surgery Journal

Volumn 28, Issue 2, 2008, Pages 189-194

  Totonchi, Ali ^a   Eshraghi, Yashar ^a   Beck, Daniel ^a   McCrae, Keith ^a   Guyuron, Bahman ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; DESMOPRESSIN;

ARTICLE; BLOOD TRANSFUSION; DEEP VEIN THROMBOSIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; FLUSHING; HEADACHE; HUMAN; HYPONATREMIA; LABORATORY TEST; PLASTIC SURGERY; PRIORITY JOURNAL; SCREENING; SIDE EFFECT; TACHYCARDIA; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

BLOOD LOSS, SURGICAL; FEMALE; HUMANS; MIDDLE AGED; SURGERY, PLASTIC; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 41149158686     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1016/j.asj.2007.12.002     Document Type: Article

References (66)

1. Fay P., Kawai Y., Wagner D., Ginsburg D., Bonthron D., Ohlsson-Wilhelm B., et al. Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science 232 (1986) 995-998
2. Joan Cox Gill M. Diagnosis and treatment of von Willebrand disease. Hematol Oncol Clin N Am 18 (2004) 1277-1299
3. Ruggeri Z., and Zimmerman T. Von Willebrand factor and von Willebrand disease. Blood 70 (1987) 895-904
4. Raines G., Aumann H., Sykes S., and Street A. Multimeric analysis of von Willebrand factor by molecular sieving electrophoresis in sodium dodecyl sulphate agarose gel. Thromb Res 60 (1990) 201-212
5. Ruggeri Z. Structure von Willebrand factor and its function in platelet adhesion and thrombus formation. Bailliere's Clin Haematol 14 (2001) 257-279
6. Budde U., and Schneppenheim R. Von Willebrand factor and von Willebrand disease. Rev Clin Exp Hematol 5 (2001) 335-368
7. Kulkarni S., Dopheide S., Yap C., Ravanat C., Freund M., Mangin P., et al. A revised model for platelet aggregation. J Clin Invest 105 (2000) 783-791
8. Kawai Y., and Montgomery R. Endothelial cell processing of von Willebrand proteins. Ann NY Acad Sci 509 (1987) 60-70
9. Montgomery R., and Scott J. Homologous functions and interactions of platelets and endothelial cells. In: Kunicki T., and George J. (Eds). Platelet immunology (1989), JB Lippincott, Philadelphia 255
10. De Marco L., Girolami A., Zimmerman T., and Ruggeri Z. Von Willebrand factor interaction with the glycoprotein IIb/IIIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. J Clin Invest 77 (1986) 1272-1277
11. De Marco L., Girolami A., Russell S., and Ruggeri Z. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to glycoprotein IIb/IIIa complex and mediates platelet aggregation. J Clin Invest 75 (1985) 1198-1203
12. Mazurier C., Goudemand J., Hilbert L., Caron C., Fressinaud E., and Meyer D. Type 2N von Willebrand disease: clinical manifestation pathophysiology, laboratory diagnosis and molecular biology. Bailliere's Clin Haematol 14 (2001) 337-347
13. Wiess H., Sussman I., and Hoyer L. Stabilization of factor VIII in plasma by the von Willebrand factor: studies on post-transfusion and dissociated factor VIII and in patients with von Willebrand disease. J Clin Invest 60 (1977) 390-404
14. Fay P., Cavallaro C., Marder V., Pancham N., Fournel M., and Schroeder D. Comparison of the in vivo survival of human factor VIII with and without von Willebrand factor in the hemophilic dog. Thromb Res 41 (1986) 425-429
15. Vlot A., Mauser-Bunschoten E., Zarkova A., Haan E., Kruitwagen C., Sixma J., et al. The half-life of infused factor VIII is shorter in hemophilic patients with blood group O than in those with blood group A. Thromb Haemost 83 (2000) 65-69
16. Rodeghiero F., Castaman G., and Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 69 (1987) 454-459
17. Miller C., Lenzi R., and Breen C. Prevalence of von Willebrand's disease among US adults. Blood 70 (1987) 377-383
18. Werner E., Emmett H., Tucker E., Giroux D., Schultz J., and Abshire T. Prevalence of von Willebrand disease in children. A multiethnic study. J Pediatr 123 (1993) 893-898
19. Gill J., Endres-Brooks J., Bauer P., Marks W., and Montgomery R. The effect of ABO blood group on the diagnoses of von Willebrand disease. Blood 69 (1987) 1691-1695
20. Ginsburg D., Handin R., Bonthron D., Donlon T., Burns G., Latt S., et al. human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 228 (1985) 1401-1406
21. Verweij C., de Vries C., istel B., van Zonneveld A., van Kessel A., van Mourik J., et al. Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene. Nucleic Acids Res 13 (1985) 4699-4717
22. Sadler J., Shelton-Inloes B., Sorace J., Harlan J., Titani K., and Davie E. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci USA 82 (1985) 6394-6398
23. Tefferi A., and Nichols W. Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis and treatment. Am J Med 103 (1997) 536-540
24. de Romeuf C., and Mazurier C. Interest of a simple and fast method for platelet von Willebrand factor characterization. Thromb Res 15 (1996) 287-298
25. Di Paolo J., Federici A., Mannucci P., Canciani M., Kritzik M., Kunicki T., et al. Low platelet α2β1 levels in type 1 von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 93 (1999) 3578-3582
26. Fressinaud E., Mazurier C., and Meyer D. Molecular genetics of type 2 von Willebrand diseases. Int J Hematol 75 (2002) 9-18
27. Nichols W., and Ginsburg D. Von Willebrand disease. Medicine 76 (1997) 1-20
28. Zimmerman T., Dent J., Ruggeri A., and Nannini L. Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individuals oligomers (type IIC, IID, and IIE). J Clin Invest 77 (1986) 947-951
29. Ginsburg D., Konkle B., Gill J., Montgomery R., Bockenstedt P., Johnson T., et al. Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA. Proc Natl Acad Sci USA 86 (1989) 3723-3727
30. Lyons S., Bruk M., Bowie E., and Ginsburg D. Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem 256 (1992) 4424-4430
31. Mancuso D., Kroner P., Christopherson P., Vokac E., Gill J., Montgomery R., et al. Type 2M: Milvaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets. Blood 88 (1996) 2559-2568
32. Hilbert L., Jenkins P., Gaucher C., Meriane E., Collins P., Pasi K., et al. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor. Thromb Haemost 84 (2000) 188-194
33. Stepanian A., Ribba A., Lavergne J., Fressinaud E., Juhan-Vague I., Mazurier C., et al. A new mutation S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease. Br J Haematol 120 (2003) 643-651
34. Franchini M. Advances in the diagnosis and management of von Willebrand disease. Hematology 11 (2006) 219-225
35. de Diego J., Prim M., Rodriguez E., Garcia J., and Mordao M. Von Willebrand disease as cause of unanticipated bleeding following adeno-tonsillectomy. Int J Pediatr Otorhinolaryngol 49 (1999) 185-188
36. Kadir R., Economides D., Sabin C., Owens D., and Lee C. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 351 9101 (1998) 485-489
37. Quik A. Telangiectasia: its relationship to the Minot-von Willebrand syndrome. Am J Med Sci 254 (1967) 585-601
38. Mannucci P., Lombardi R., Bader R., et al. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. Blood 66 (1985) 796-802
39. Weiss H., Pietu G., Rabinowitz R., Girma J., Rogers J., and Meyer D. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (IIA) von Willebrand's disease. J Lab Clin Med 101 (1983) 411-425
40. Favaloro E., Lillicarp D., Lazzari M., et al. von Willebrand disease: laboratory aspects of diagnosis and treatment. Haemophilia 10 Suppl 4 (2004) 164-168
41. Laffan M., Brown S., Collins P., et al. The diagnosis of von Willebrand disease: A guideline from the UK Haemophilia Centre doctors' Organization. Haemophilia 10 (2004) 199-217
42. Weiss H., Meyer D., Rabinowitz R., et al. Pseudo-von Willebrand's disease. An intrinsic Pseudo- von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified Human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weigh Multimers. N Engl J Med 306 (1982) 326-333
43. Miller J., and Castella A. Platelet-type von Willebrand's disease: Characterization of a new bleeding Disorder. Blood 60 (1982) 790-794
44. Mannucci P. Hemostatic drugs. N Engl J Med 339 (1998) 245-253
45. Nishino M., Girma J., Rothschild C., Fressinaud E., and Meyer D. New variant of von Willebrand disease with defective binding to factor VIII. Blood 74 (1989) 1591-1599
46. Mazurier C., Dieval J., Jorieux S., Delobel J., and Goudemand M. A new von Willebrand factor (vWF) Defect in a patient factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 75 (1990) 20-26
47. Fressinaud E., Veyradier A., Trichaud F., et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 91 (1998) 1325-1331
48. Franchini M. the platelet function analyzer (PFA-100): An updates on its clinical use. Clin Lab 51 (2005) 367-372
49. Pasi K., Collins P., Keeling D., et al. Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia 10 (2004) 218-231
50. Mannuci P. Treatment of von Willebrand's disease. N Engl J Med 351 (2004) 683-694
51. Casonato A., Sartori M., DeMarco L., Girolami A., et al. 1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type II-B von Willebrand's disease: shortening of bleeding time and induction of variable pseudothrombocytopenia. Thromb Haemost 64 (1990) 117-120
52. Mannucci P., and Lusher J. Desmopressin and thrombosis. Lancet 2 (1989) 675
53. Mannucci P. desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years. Haemophilia 6 Suppl. 1 (2000) 60-67
54. Mannucci P., and Federici A. Management of inherited von Willebrand disease. Best Pract Res Clin Haematol 14 (2001) 455-462
55. Rodeghiero F., Castaman G., and Mannucci P. Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand disease. Blood Rev 5 (1991) 155-161
56. Mannucci P., Chediak J., Hanna W., Byrnes J., Marlies L., Ewensrein B., and the Alphanate Study Group. Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. Blood 99 (2002) 450-456
57. Franchini M., Rossetti G., Talia Ferri A., Pattacini C., Pozzoli D., Lippi G., et al. Efficacy and safety of factor VIII/von Willebrand factor concentrate (haemate-P) in preventing bleeding during surgery or invasive procedure in patients with von Willebrand's Disease. Haematologia 88 (2003) 1279-1283
58. Rosendaal F. High levels of factor VIII and venous thrombosis. Thromb Haemost 83 (2000) 1-2
59. Mannucci P. Venous thromboembolism in von Willebrand disease. Thromb Haemost 88 (2002) 378-379
60. Makris M., Colvin B., Gupta V., Shields M., and Smith M. Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand disease. Thromb Haemost 88 (2002) 387 288
61. Rodeghiero F., and Castaman G. Treatment of von Willebrand disease. Semin Hematol 42 (2005) 29-35
62. Mannucci P., and Tedesco F. Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor. Eur J Haematol 39 (1987) 467-470
63. Von Willebrand E. Hereditar pseudohemifi. Finska Lak Hand 68 (1926) 87-112
64. Guyuron B., Zarandy S., and Tirgan A. Von Willebrand's disease and plastic surgery. Ann Plast Surg 32 (1994) 351-355
65. Johnson G. Hemorrhage from the cosmetic otoplasty of Doberman pinschers with von Willebrand's disease. Am J Veterinary Res 46 (1985) 1335-1340
66. Physician desk reference, 60th edition, pages: 2893-2894.